Abstract
Thirteen GH-deficient HPA (7 M and 6 F; aged 24-65 years) were followed for 4 years on uninterrupted GH treatment. Their weight, body mass index (BMI) and waist to hip circumference ratio (WHR) were assessed, their fasting insulin-like growth factor I (IGF-I), total cholesterol (T-C), LDL cholesterol (LDL-C), triglycerides (TG), HDL cholesterol (HDL-C), glucose and insulin were measured, and a 3-h 75 g OGTT was performed. Compared to pretreatment levels, fasting IGF-I levels increased significantly at 1, 2, 3 & 4 years (p = 0.0001, p = 0.0004, p = 0.006 and p = 0.002, respectively). Body weight and BMI did not change significantly at 1, 2 & 3 years but increased minimally at 4 years (p = 0.012 p = 0.009), and WHR decreased significantly at 1, 2 & 4 years (p = 0.0025, p = 0.012, p = 0.047). Fasting T-C and LDL-C decreased significantly at one year (p = 0.02, p = 0.005) and the reductions have been maintained throughout the treatment period. TG and HDL-C did not change significantly. Fasting and post-prandial hyperglycemia had appeared at one year (p = 0.016, p = 0.07), but disappeared with time. This was also true for the post-prandial but not the fasting hyperinsulinemia. In conclusion, four years of GH treatment in HPA is associated with preserved beneficial effects on anthropometry and lipid metabolism. A sustained minor fasting hyperinsulinemic action was observed the significance of which requires longer periods of follow up.
| Original language | English |
|---|---|
| Pages (from-to) | 53 |
| Number of pages | 1 |
| Journal | Endocrinology and Metabolism, Supplement |
| Volume | 4 |
| Issue number | A |
| State | Published - 1997 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'P-047. Anthropometric and metabolic effects of four years treatment with biosynthetic human growth hormone (GH) in hypopituitary adults (HPA)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver